INS and type 2 diabetes mellitus: A similar 2017 study of 60 T2DM subjects with inadequately controlled insulin on metformin and basal-bolus insulin found a 0.73% and 1.13% reduction in HbA1C relative to baseline and placebo (p<0.001), respectively, with the administration of BC-QR [46].